We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Proton Magnetic Resonance Spectroscopy of Normal Breast Tissues in Women Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00155090
Recruitment Status : Unknown
Verified January 2005 by National Taiwan University Hospital.
Recruitment status was:  Recruiting
First Posted : September 12, 2005
Last Update Posted : September 12, 2005
Information provided by:
National Taiwan University Hospital

Brief Summary:
Magnetic resonance spectroscopy (MRS) is a diagnostic technique in MRI that distinguishes various metabolites on the basis of their slightly different chemical shifts or resonance frequencies. The Proton is the most abundant nucleus in the body. We will try to establish the typical proton MRS pattern of normal women breasts to be a guideline for future further investigations.

Condition or disease
Breast Neoplasms

Detailed Description:
There are few reports regarding proton MRS in normal female breasts. The fibroglandular tissues and fat are the two major gross components in the breast. The water content in the fibroglandular tissues is much higher than that in the fat. There is still no documented report discussing proton MRS in normal female breasts of premenopausal and postmenopausal women. Our study is to evaluate the proton MRS findings among normal premenopausal and postmenopausal women breasts, to find out if there are statistical differences on the main proton MRS patterns, water and lipid peak intensities and ratios between the two groups.

Study Type : Observational
Estimated Enrollment : 80 participants
Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Study Start Date : January 2005
Estimated Study Completion Date : December 2005

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   30 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • women age ranged 30 years of age or older, with normal mammograms or ultrasound in recent 3 months

Exclusion Criteria:

  • any women not fulfilling the inclusion criteria

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00155090

Contact: Jane Wang, MD 886-2-23123456 ext 5565 hstjen@yahoo.com.tw

National Taiwan University Hospital Recruiting
Taipei, Taiwan, 100
Contact: Jane Wang, MD    886-2-23123456 ext 5565    hstjen@yahoo.com.tw   
Principal Investigator: Jane Wang, MD         
Sponsors and Collaborators
National Taiwan University Hospital
Principal Investigator: Jane Wang, MD National Taiwan University Hospital

ClinicalTrials.gov Identifier: NCT00155090     History of Changes
Other Study ID Numbers: 9361700788
First Posted: September 12, 2005    Key Record Dates
Last Update Posted: September 12, 2005
Last Verified: January 2005

Keywords provided by National Taiwan University Hospital:
Magnetic resonance imaging,
breast disease

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases